130 related articles for article (PubMed ID: 28068077)
1. Interactions of Nitroxide-Conjugated and Non-Conjugated Glycodendrimers with Normal and Cancer Cells and Biocompatibility Studies.
Andreozzi E; Antonelli A; Cangiotti M; Canonico B; Sfara C; Pianetti A; Bruscolini F; Sahre K; Appelhans D; Papa S; Ottaviani MF
Bioconjug Chem; 2017 Feb; 28(2):524-538. PubMed ID: 28068077
[TBL] [Abstract][Full Text] [Related]
2. Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer.
Ziemba B; Franiak-Pietryga I; Pion M; Appelhans D; Muñoz-Fernández MÁ; Voit B; Bryszewska M; Klajnert-Maculewicz B
Int J Pharm; 2014 Jan; 461(1-2):391-402. PubMed ID: 24361266
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of Internalization of Maltose-Modified Poly(propyleneimine) Glycodendrimers into Leukemic Cell Lines.
Studzian M; Szulc A; Janaszewska A; Appelhans D; Pułaski Ł; Klajnert-Maculewicz B
Biomacromolecules; 2017 May; 18(5):1509-1520. PubMed ID: 28414464
[TBL] [Abstract][Full Text] [Related]
4. Glycodendrimer PPI as a Potential Drug in Chronic Lymphocytic Leukaemia. The Influence of Glycodendrimer on Apoptosis in In Vitro B-CLL Cells Defined by Microarrays.
Franiak-Pietryga I; Ziółkowska E; Ziemba B; Appelhans D; Maciejewski H; Voit B; Kaczmarek A; Robak T; Klajnert-Maculewicz B; Cebula-Obrzut B; Smolewski P; Borowiec M; Bryszewska M
Anticancer Agents Med Chem; 2017; 17(1):102-114. PubMed ID: 27349446
[TBL] [Abstract][Full Text] [Related]
5. Sugar-modified poly(propylene imine) dendrimers as drug delivery agents for cytarabine to overcome drug resistance.
Szulc A; Pulaski L; Appelhans D; Voit B; Klajnert-Maculewicz B
Int J Pharm; 2016 Nov; 513(1-2):572-583. PubMed ID: 27667754
[TBL] [Abstract][Full Text] [Related]
6. Dense shell glycodendrimers as potential nontoxic anti-amyloidogenic agents in Alzheimer's disease. Amyloid-dendrimer aggregates morphology and cell toxicity.
Klementieva O; Benseny-Cases N; Gella A; Appelhans D; Voit B; Cladera J
Biomacromolecules; 2011 Nov; 12(11):3903-9. PubMed ID: 21936579
[TBL] [Abstract][Full Text] [Related]
7. Interaction study between maltose-modified PPI dendrimers and lipidic model membranes.
Wrobel D; Appelhans D; Signorelli M; Wiesner B; Fessas D; Scheler U; Voit B; Maly J
Biochim Biophys Acta; 2015 Jul; 1848(7):1490-501. PubMed ID: 25843678
[TBL] [Abstract][Full Text] [Related]
8. Effect of poly(propylene imine) glycodendrimers on β-amyloid aggregation in vitro and in APP/PS1 transgenic mice, as a model of brain amyloid deposition and Alzheimer's disease.
Klementieva O; Aso E; Filippini D; Benseny-Cases N; Carmona M; Juvés S; Appelhans D; Cladera J; Ferrer I
Biomacromolecules; 2013 Oct; 14(10):3570-80. PubMed ID: 24004423
[TBL] [Abstract][Full Text] [Related]
9. Fludarabine-Specific Molecular Interactions with Maltose-Modified Poly(propyleneimine) Dendrimer Enable Effective Cell Entry of the Active Drug Form: Comparison with Clofarabine.
Gorzkiewicz M; Deriu MA; Studzian M; Janaszewska A; Grasso G; Pułaski Ł; Appelhans D; Danani A; Klajnert-Maculewicz B
Biomacromolecules; 2019 Mar; 20(3):1429-1442. PubMed ID: 30707833
[TBL] [Abstract][Full Text] [Related]
10. Generation dependent cancer targeting potential of poly(propyleneimine) dendrimer.
Kesharwani P; Tekade RK; Jain NK
Biomaterials; 2014 Jul; 35(21):5539-48. PubMed ID: 24731713
[TBL] [Abstract][Full Text] [Related]
11. Poly(propyleneimine) glycodendrimers non-covalently bind ATP in a pH- and salt-dependent manner - model studies for adenosine analogue drug delivery.
Gorzkiewicz M; Buczkowski A; Appelhans D; Voit B; Pułaski Ł; Pałecz B; Klajnert-Maculewicz B
Int J Pharm; 2018 Jun; 544(1):83-90. PubMed ID: 29653214
[TBL] [Abstract][Full Text] [Related]
12. Characterization of a fluorescent 1,8-naphthalimide-functionalized PAMAM dendrimer and its Cu(ii) complexes as cytotoxic drugs: EPR and biological studies in myeloid tumor cells.
Canonico B; Cangiotti M; Montanari M; Papa S; Fusi V; Giorgi L; Ciacci C; Ottaviani MF; Staneva D; Grabchev I
Biol Chem; 2022 Feb; 403(3):345-360. PubMed ID: 34883001
[TBL] [Abstract][Full Text] [Related]
13. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs.
Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S
Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613
[TBL] [Abstract][Full Text] [Related]
14. Reducing cytotoxicity while improving anti-cancer drug loading capacity of polypropylenimine dendrimers by surface acetylation.
Wang F; Cai X; Su Y; Hu J; Wu Q; Zhang H; Xiao J; Cheng Y
Acta Biomater; 2012 Dec; 8(12):4304-13. PubMed ID: 22842039
[TBL] [Abstract][Full Text] [Related]
15. Influence of surface groups on poly(propylene imine) dendrimers antiprion activity.
McCarthy JM; Rasines Moreno B; Filippini D; Komber H; Maly M; Cernescu M; Brutschy B; Appelhans D; Rogers MS
Biomacromolecules; 2013 Jan; 14(1):27-37. PubMed ID: 23234313
[TBL] [Abstract][Full Text] [Related]
16. Interactions between U-937 human macrophages and poly(propyleneimine) dendrimers.
Kuo JH; Jan MS; Lin YL
J Control Release; 2007 Jul; 120(1-2):51-9. PubMed ID: 17537537
[TBL] [Abstract][Full Text] [Related]
17. Poly (propyleneimine) dendrimer based nanocontainers for targeting of efavirenz to human monocytes/macrophages in vitro.
Dutta T; Agashe HB; Garg M; Balakrishnan P; Kabra M; Jain NK
J Drug Target; 2007 Jan; 15(1):89-98. PubMed ID: 17365278
[TBL] [Abstract][Full Text] [Related]
18. Anti-Tumour Activity of Glycodendrimer Nanoparticles in a Subcutaneous MEC-1 Xenograft Model of Human Chronic Lymphocytic Leukemia.
Ziemba B; Sikorska H; Jander M; Kuncman W; Danilewicz M; Appelhans D; Bryszewska M; Borowiec M; Franiak-Pietryga I
Anticancer Agents Med Chem; 2020; 20(3):325-334. PubMed ID: 31738155
[TBL] [Abstract][Full Text] [Related]
19. Terminal Sugar Moiety Determines Immunomodulatory Properties of Poly(propyleneimine) Glycodendrimers.
Gorzkiewicz M; Sztandera K; Jatczak-Pawlik I; Zinke R; Appelhans D; Klajnert-Maculewicz B; Pulaski Ł
Biomacromolecules; 2018 May; 19(5):1562-1572. PubMed ID: 29569917
[TBL] [Abstract][Full Text] [Related]
20. Ligand anchored dendrimers based nanoconstructs for effective targeting to cancer cells.
Gupta U; Dwivedi SK; Bid HK; Konwar R; Jain NK
Int J Pharm; 2010 Jun; 393(1-2):185-96. PubMed ID: 20382210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]